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Abstract 
Background : To compare low dose peri-operative 
lidocaine infusion and placebo for post-operative 
mean pain score and mean analgesic requirement in 
open cholecystectomy. 
Methods:  In this prospective randomized 
comparative study 120 patients, undergoing open 
cholecystectomy in general anaesthesia,  were 
included. Patients were randomly allocated to either 
lidocaine infusion (L) or saline group (S) using 
systematic randomized sampling with 60 patients in 
each group. Patients in the lidocaine infusion group 
were given bolus injection of lidocaine 30 minutes 
before the skin incision followed by a continuous 
intraveonous via infusion pump whereas the 
patients in the saline group received 0.9% normal 
saline in equal volume and in the same manner. The 
infusion was continued throughout the surgery and 
was terminated 60 min after the skin closure. 
Results: Out of the 120 patients 34 (28.3%) were 
male while 86 (71.7%) were female. Mean age was 
41.32±11.512 years. Both mean VAS pain score and 
mean analgesic requirement were found to be 
significantly lower in the lidocaine Group (p-values 
0.04 and 0.29 respectively), as compared to controls. 
Conclusion: Peri-operative low dose systemic 
lidocaine appears to reduce pain in the immediate 
post-operative period. . 
Key words: Lidocaine, Post-operative Pain, Open 
Cholecystectomy. 
 
Introduction 
Post-operative pain has unpleasant nature and 
physiological consequences. Search for safe and 
effective modalities for post-operative pain relief has 
been of great interest for perioperative physicians. 
Optimal post-operative pain relief not only increases 
patient’s comfort but also intensifies his satisfaction 
towards surgery. Provision of effective analgesia in 
post-operative periods also facilitates early 
mobilization and rehabilitation of patients. Optimal 
post-operative pain control is associated with less 
post-operative cognitive impairment, enhanced quality 
of life and less risk of chronic post-surgical pain. 
Effective post-operative pain relief leads to shortened 
hospital stay, reduces hospital costs and increased 
patient’s satisfaction.NSAIDS are commonly used for 
post-operative pain relief, they are easy to use but only 
ketorolac is available in injectable form. These drugs 
have potential deleterious effects on gastric and renal 
functions.Opioids are the most commonly used drugs 
for post-operative pain relief. They provide excellent 
pain relief but they can cause delay in recovery time, 
nausea and vomiting and respiratory 
depression.Regional techniques may also be used for 
effective post-operative pain control. 1,2 
Lidocaine , is amino amide type local anesthetic and 
class 1B antiarrhythmic drug. It has rapid onset of 
action and intermediate duration of action. Its use in 
chronic neuropathic pain is well established.3 Now 
peri-operative use of lidocaine for post-operative pain 
relief is a topic of interest.4 Peri operative systemic 
lidocaine has beneficial post-operative analgesic 
effects.5 It also reduces post-operative analgesic 
requirement.3, 6,7 
Baral  BK et al and colleagues conducted a study in 60 
patients undergoing upper abdominal surgery. Thirty  
patients received 2%lidocaine infusion and 30 patients 
received normal saline according to randomization. 
Post-operative analgesic requirement were 
significantly reduced (142.50±37.80mg 
Vs185.00±41.31mg p<0.001) in lidocaine Group as 
compared to control group.6 One study shows that 
post-operative pain intensity is less in lidocaine group 
(visual analogue scale score 3.1±2.04 vs 4.5±2.9; p = 
0.043).8 Another study showed that there is no 
significant beneficial effect of peri-operative lidocaine 
infusion on post-operative pain relief VAS (3.5 ± 1.7) in 
control group vs. (3.4 ±1.6) in lidocaine group. 
Perioperative lidocaine administration has no 
influence on postoperative analgesic consumption.9 
Postoperative pain is a major issue after every surgical 
procedure and is a burden on hospitals because 
different modalities are used for postoperative pain 
relief.Lidocaine infusion is not used for postoperative 
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pain relief locally and no local study is available on 
lidocaine for postoperative pain relief although it is an 
effective modality to control postoperative pain while 
there are international studies showing controversy in 
its effectiveness as an analgesic. 
 
Patients and Methods 
This  prospective randomized comparative study was 
conducted by the Department of Anaesthesia at 
Benazir Bhutto Hospital, Rawalpindi, for 6 months 
from  March, 2014 to  August, 2014. Patients of elective 
cholecystectomy,patients of age 18- 60 years and 
patients of ASA I and ASA II physical status  were 
included . Patients with emergency surgery, with 
known hepatic or renal dysfunction,  with cardiac 
dysrhythmias /atrioventricular block, having and 
anticipated duration of surgery more than 3 hours and 
with a known hypersensitivity/allergy to the study 
medication were  excluded. Patients were randomly 
allocated to either lidocaine infusion (L) or saline 
group (S) using systematic randomized sampling. 
Patients in the lidocaine infusion group were given 
bolus injection of lidocaine (1.5 mg/kg slowly over 10 
min) 30 minutes before the skin incision followed by a 
continuous IV infusion at the rate of 1.5 mg/kg/h via 
infusion pump whereas the patients in the saline 
group received 0.9% normal saline in equal volume 
and in the same manner. The infusion was continued 
throughout the surgery and was terminated 60 min 
after the skin closure. Patients were pre-medicated 
with inj midazolam 1mg IV 2 hours prior to surgery.  
In all the patients, anesthesia was induced with 
inj.propofol 2.0 mg/kg, nalbuphine 0.1 mg/kg, 
followed by atracurium 0.5 mg/kg intravenously to 
facilitate the laryngoscopy and orotracheal intubation. 
After tracheal intubation, anesthesia was maintained 
with sevoflurane and 50%oxygen+50%N2O with 
intermittent intravenous boluses of atracurium 10 mg 
after every 20 min. After completion of surgery, 
inhalational anesthetics were stopped and the residual 
neuromuscular blockade was antagonized with the 
mixture of inj. neostigmine 0.05mg/kg and atropine 
0.02mg/kg IV. Infusion was continued for further 1 
hour.Severity of pain was monitored at 0 min, 30 min 
and 60 min in the immediate post-operative period. 
The severity of pain was assessed by asking the patient 
to indicate on the 10 cm line at the point that 
corresponded to the level of pain intensity they felt. 
The distance in Centimeter from no pain end of visual 
analogue scale (VAS) to the patient’s mark was used as 
a numerical index of the severity of pain.Any patient 
complaining of pain immediately after extubation was 
considered to have a pain VAS more than 4 and was 
managed accordingly. A patient with VAS score of 
more than four was treated with inj. Diclofenac 
sodium 75 mg IM. If the patient’s VAS remained more 
than four even after 30 minutes of inj. diclofenac 
sodium then inj. tramadol 100mg IV was given as 
rescue analgesic. Further and subsequent doses of 
diclofenac were allowed after an interval of 6 hours 
without exceeding a total dose of 225mg in 24 
hours.After one hour of observation, the patient was 
shifted to the surgical ward from the PACU where the 
severity of pain was again measured at 8, 16 and 24 
hours post-op. The number of cumulative doses of 
Injection diclofenac and tramadol given during study 
period were recorded. If any signs of systemic toxicity 
or hypersensitivity reaction of the drugs were 
encountered, they were treated accordingly and 
patient was excluded from the study. 
 
Results 
One hundred and twenty patients were randomized 
into two groups by the lottery method. Sixty patients 
were allocated to the Lidocaine group while 60 
patients were allocated to the Control group. Mean age 
of the patients in the study was 41.32±11.512 years. 
Mean VAS scale pain score was 3.5±1.604 and the 
mean analgesia requirement was 78.75±62.9 mg.There 
were 34 male patients while 86 patients were female. 
In the Control Group the mean age of the patients was 
41.43±11.238 years, mean VAS pain score was 
3.8±1.802 and mean Analgesia requirement was 
91.25±64.903 mg (Table 1).  
Table 1 Comparison of mean VAS pain scores 
between patients belonging to Lidocaine group 
and Control Group (n=120) 
 
Mean VAS Pain 
Score 
 
p-Value 
Lidocaine Group 3.2±1.325  
0.04 Control Group 3.8±1.802 
 
Table 2 Comparison of mean Analgesia 
requirement between patients belonging to 
Lidocaine group and Control Group (n=120) 
 Mean Analgesia 
requirement in 
mg 
 
p-Value 
Lidocaine 
Group 
66.25±58.734  
0.029 
Control Group 91.25±64.903 
There were 18 male patients (30%) and 42 female 
patients (70%) in this group.Mean VAS pain score was 
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3.2±1.325 and mean analgesia requirement was 
66.25±58.734 mg. The mean VAS pain score and the 
mean analgesia requirement were compared between 
the two groups using independent sample t-test (Table 
2). 
 
Discussion 
The mean age in our study was 41.32±11.512 years 
while female patients were 86 (71.7%) in number. This 
is in line with the so called famous 5 F’s of 
Cholelithiasis  which include Female and Forty. 10 The 
presentation of patients in our study demonstrates that 
the international epidemiological data presented on 
cholelithiasis also holds true in our region, which 
shows the same epidemiology as the rest of the 
world.The mean VAS pain score of patients treated 
with lidocaine infusion peri-operatively in our study 
was found to be 3.2±1.325, which is significantly less as 
compared to the mean score of patients treated with 
placebo, 3.8±1.802. This finding can be compared with 
the results of McKay et al. whose study also showed a 
significant difference between the two groups7. These 
findings can also be correlated to some other studies 
which have shown similar results.3, 5, 11 
The mean dose of Analgesic required by the patients in 
the Lidocaine group, 66.25±58.734, was also 
significantly lower than the mean dose required by 
patients in the placebo group, 91.25±64.903. This also 
validates the results of McKay et al. and Baral BK et 
al.7, 8 These results can also be compared with other 
studies which demonstrated the efficacy of Lidocaine 
infusion peri-operatively in reducing post-op pain.2, 
3,12, 13 
The results of our study are in contrast to the study 
done by Wuethrich PY et al. whose study did not show 
any benefit of lidocaine infusion. This may be due to 
the difference in the outcome variable, the small 
sample size of Wuethrich PY et al. and the nature of 
the procedure. As compared to 120 patients in our 
study Wuethrich PY et al. had only 64 patients with 
the outcome variable of length of hospital stay. The 
patients in the study done by Wuethrich PY et al. 
underwent Laparoscopic Renal surgery conferring the 
benefit of Laparoscopy in the form of reduced post-op 
pain and early ambulation.9 
There is a growing body of data suggesting the role of 
lidocaine in pain management in the immediate post-
operative period but data also suggests that although 
lidocaine reduces post-operative pain and analgesic 
requirement, it does not affect the length of hospital 
stay and discharge timing of the patient.8, 9Intravenous 
lidocaine should not be used in patients with 
arrhythmias, heart failure, coronary  artery disease, 
Adams-Strokes or heart block and may be used with 
caution in patients with liver failure, sinusoidal 
bradycardia and incomplete branch block.14-17 
Most common side-effects are in general mild and 
relate to central nervous system. Patients may present 
with: sleepiness, dizziness, metal taste, headache, 
blurred vision, paresthesia, dysarthria, euphoria and 
nausea.18-20 Higher doses rapidly administered may 
cause tinnitus, shivering and agitation.21,22 
Cardiovascular changes are in general minimal with 
usual doses.23,24 A meta-analysis on the use of 
intravenous lidocaine in abdominal surgeries reports 
that with regard to infusion dose beginning and 
duration there is still not a consensus.25 
Conclusion 
Lidocaine reduces mean VAS pain score and mean 
analgesic requirement in patients undergoing Open 
Cholecystectomy. 
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